Single-Cell Analysis Reveals EP4 as a Target for Restoring T Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy

Investigators identified EP4 as a specific target for prostate cancer immunotherapy and demonstrated that YY001 inhibited the growth of prostate tumors by regulating the immune microenvironment and strongly synergized with anti-programmed cell death protein-1 antibodies.